Pages
All Departments
Let's get Social
Copyright Here. All rights reserved.
BYWWW.NEJM.ORGJuly 14, 2017
We randomly assigned 1110 patients with clear-cell, metastatic renal-cell carcinoma, in a 1:1 ratio, to receive a continuous dose of pazopanib (800 mg once daily; 557 ...